Pfizer to depart GSK's ViiV as Shionogi doubles its stake
辉瑞将退出葛兰素史克旗下的ViiV Healthcare（ViiV医疗保健有限公司），盐野义制药将持股比例翻倍

Pfizer is walking away from a specialist HIV company it created together with GSK more than a decade ago, with Shionogi taking its place.
辉瑞将退出其与葛兰素史克在十多年前共同创立的专业HIV公司，由盐野义制药接替其位置。